All Resources
Accelerate Immunotherapy Development

Learn how to accelerate immune therapy development from pre-clinical to clinical stages with our Single-Cell Functional Proteomics.

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this E-Book we discuss:

Introduction to Cell Therapy: CAR-T therapies have transformed Immunotherapy
Single-Cell Functional Proteomics: a power tool for immune profiling
Introduction to Checkpoint Therapy: an overview and analysis
Our three-step single-cell proteomics workflow
A Deeper Look

More about this E-Book

Accelerating Novel Immunotherapies

In developing immunotherapies, processes, and biomarkers are made more complex by the highly heterogenous T cells that form the basis for the therapeutic product or drive the anti-tumor response in various checkpoint and antibody-based immunotherapies.

Bruker Cellular Analysis provides actionable potency, safety, and patient-difference metrics by detecting highly potent single-cell functional subsets.

Download this eBook to learn how these technological advancements drastically accelerate the development of novel immunotherapies.

Get the E-Book